Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-15,000
Closed -$12.5M 41
2016
Q2
$12.5M Hold
15,000
0.17% 29
2016
Q1
$13.7M Hold
15,000
0.23% 19
2015
Q4
$15.4M Hold
15,000
0.21% 30
2015
Q3
$14.2M Hold
15,000
0.17% 30
2015
Q2
$15.7M Buy
+15,000
New +$15.7M 0.17% 35

Other funds holding AGN.PRA

Corvex Management's AGN.PRA Position: Q3 2016 in Review

Corvex Management sold out of Allergan plc (AGN.PRA) in Q3 2016, closing a stake of 15,000 shares — an estimated $12.5M sold.

Corvex Management first reported a position in AGN.PRA in Q2 2015 and held it in 5 quarters. The position peaked at $15.7M in Q2 2015. 117 funds tracked by Wall St. Rank hold AGN.PRA as of Q3 2016.

  • Corvex Management reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Corvex Management sold 15,000 Allergan plc shares in Q3 2016, an estimated $12.5M.
  • Corvex Management first reported a position in Allergan plc in Q2 2015 and held it in 5 quarters.
  • Corvex Management's Allergan plc position peaked at $15.7M in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Corvex Management's 13F filing for Q3 2016, filed 14 Nov 2016.